Reactogenicity, Safety and Immunogenicity of QazCovid-in® COVID-19 Vaccine

Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2020
Randomized, blind, placebo-controlled phase- i study and randomized, open phase phase-ii study of QAZCOVID-IN®- COVID-19 inactivated vaccine in healthy adult volunteers from 18 years old and elder
Epistemonikos ID: a1dc866c3e69cfd88a77bae19633027a41848291
First added on: Aug 29, 2020